eli lilly retatrutide phase 3 trial Lilly's triple agonist delivers up to 71.2 lbs of weight loss Eli Lilly said Thursday its

Weve curated this roundup to give our readers a snippet of whats happening in the health and wellness space, accompanied by expert commentary for those who want to learn more

The larger the cannula caliber, the more aggressively the fat can be removed

The injection process begins with site selection and preparation

The main difference is that MT-1 is a straight peptide that is a full clone of endogenous -MSH while MT-2 is a circular peptide that's just a partial copy of the version made naturally in the body

While Retatrutide is not yet FDA-approved, exciting results from ongoing clinical trials have the weight loss community buzzing